P-094 - UTILIZATION OF PHARMACOGENOMIC INFORMATION IN BIOEQUIVALENCE STUDIES FOR GENERIC DRUG DEVELOPMENT.

K. Li, H. Boyce, S. Lee, M. Frost, M. Kim, J. Shon; US Food and Drug Administration, Silver Spring, MD, USA.

Presenting Author(s)

Karen Li, PharmD

US Food and Drug Administration
Silver Spring, Maryland, United States